1-5 of 5
Hendrik De Raeve
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro, Ex Vivo, and In Vivo in the 5T33MM Mouse Model

Pedram Kharaziha, Hendrik De Raeve, Charlotte Fristedt, Qiao Li, Astrid Gruber, Per Johnsson, Georgia Kokaraki, Maria Panzar, Edward Laane, Anders Österborg, Boris Zhivotovsky, Helena Jernberg-Wiklund, Dan Grandér, Fredrik Celsing, Magnus Björkholm, Karin Vanderkerken, Theocharis Panaretakis
Journal: Cancer Research
Cancer Res (2012) 72 (20): 5348–5362.
https://doi.org/10.1158/0008-5472.CAN-12-0658
Published: 14 October 2012
View article titled, Sorafenib Has Potent Antitumor Activity against Multiple Myeloma <em>In Vitro</em>, <em>Ex Vivo</em>, and <em>In Vivo</em> in the 5T33MM Mouse Model
Open the PDF for Sorafenib Has Potent Antitumor Activity against Multiple Myeloma <em>In Vitro</em>, <em>Ex Vivo</em>, and <em>In Vivo</em> in the 5T33MM Mouse Model in another window
Includes: Supplementary data
Journal Articles

Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma

Sarah Deleu, Miguel Lemaire, Janine Arts, Eline Menu, Els Van Valckenborgh, Isabelle Vande Broek, Hendrik De Raeve, Les Coulton, Ben Van Camp, Peter Croucher, Karin Vanderkerken
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5307–5311.
https://doi.org/10.1158/0008-5472.CAN-08-4472
Published: 01 July 2009
View article titled, Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma
Open the PDF for Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma in another window
Journal Articles

Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma

Karin Vanderkerken, Satya Medicherla, Les Coulton, Hendrik De Raeve, Angelo Willems, Michelle Lawson, Ben Van Camp, Andrew A. Protter, Linda S. Higgins, Eline Menu, Peter I. Croucher
Journal: Cancer Research
Cancer Res (2007) 67 (10): 4572–4577.
https://doi.org/10.1158/0008-5472.CAN-06-4361
Published: 17 May 2007
View article titled, Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma
Open the PDF for Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma in another window
Journal Articles

A Unique Pathway in the Homing of Murine Multiple Myeloma Cells: CD44v10 Mediates Binding to Bone Marrow Endothelium

Kewal Asosingh, Ursula Günthert, Hendrik De Raeve, Ivan Van Riet, Ben Van Camp, Karin Vanderkerken
Journal: Cancer Research
Cancer Res (2001) 61 (7): 2862–2865.
Published: 01 April 2001
View article titled, A Unique Pathway in the Homing of Murine Multiple Myeloma Cells: <subtitle>CD44v10 Mediates Binding to Bone Marrow Endothelium</subtitle>
Open the PDF for A Unique Pathway in the Homing of Murine Multiple Myeloma Cells: <subtitle>CD44v10 Mediates Binding to Bone Marrow Endothelium</subtitle> in another window
Journal Articles

In Vivo Induction of Insulin-like Growth Factor-I Receptor and CD44v6 Confers Homing and Adhesion to Murine Multiple Myeloma Cells

Kewal Asosingh, Ursula Günthert, Marleen H. C. Bakkus, Hendrik De Raeve, Eva Goes, Ivan Van Riet, Ben Van Camp, Karin Vanderkerken
Journal: Cancer Research
Cancer Res (2000) 60 (11): 3096–3104.
Published: 01 June 2000
View article titled, <em>In Vivo</em> Induction of Insulin-like Growth Factor-I Receptor and CD44v6 Confers Homing and Adhesion to Murine Multiple Myeloma Cells
Open the PDF for <em>In Vivo</em> Induction of Insulin-like Growth Factor-I Receptor and CD44v6 Confers Homing and Adhesion to Murine Multiple Myeloma Cells in another window